GGrantIndex
← Search

IMAGING CORE

$64,603P30FY2011CANIH

Emory University, Atlanta GA

Investigators

Linked publications, trials & patents

Trial NCT07405476Trial NCT07213154Trial NCT07174570Trial NCT07155317Trial NCT07150546Trial NCT07140679Trial NCT07112690Trial NCT07104240Trial NCT07101445Trial NCT06914999Trial NCT06868433Trial NCT06865768Trial NCT06799481Trial NCT06760507Trial NCT06731270Trial NCT06709534Trial NCT06708351Trial NCT06674863Trial NCT06662058Trial NCT06650579Trial NCT06636734Trial NCT06595160Trial NCT06583148Trial NCT06541158Trial NCT06534125Trial NCT06495125Trial NCT06492759Trial NCT06492070Trial NCT06423326Trial NCT06328699Trial NCT06328686Trial NCT06324240Trial NCT06254911Trial NCT06132685Trial NCT06105918Trial NCT06008730Trial NCT06006013Trial NCT05998135Trial NCT05877859Trial NCT05873608Trial NCT05798507Trial NCT05779943Trial NCT05756569Trial NCT05733351Trial NCT05526872Trial NCT05514912Trial NCT05513859Trial NCT05506982Trial NCT05493566Trial NCT05488145Trial NCT05464810Trial NCT05391750Trial NCT05387915Trial NCT05368428Trial NCT05346692Trial NCT05341349Trial NCT05320406Trial NCT05315687Trial NCT05310448Trial NCT05274763Trial NCT05250895Trial NCT05245682Trial NCT05244239Trial NCT05208307Trial NCT05204160Trial NCT05103904Trial NCT05091866Trial NCT05086731Trial NCT05039073Trial NCT05017610Trial NCT04908709Trial NCT04895592Trial NCT04890236Trial NCT04883437Trial NCT04878029Trial NCT04848519Trial NCT04776395Trial NCT04762199Trial NCT04754945Trial NCT04750473Trial NCT04731376Trial NCT04725903Trial NCT04676087Trial NCT04590664Trial NCT04585724Trial NCT04524702Trial NCT04483206Trial NCT04433949Trial NCT04428671Trial NCT04393350Trial NCT04366791Trial NCT04361552Trial NCT04352205Trial NCT04348292Trial NCT04340882Trial NCT04278118Trial NCT04276194Trial NCT04262869Trial NCT04191421Trial NCT04144127

Abstract

The Cell Imaging and Microscopy Core (CIMC) provides cellular imaging technologies and services to enhance the programmatic research initiatives of the Winship Cancer Institute (WCI). It is centrally located in the WCI and houses state-of-the-art technologies including point scanning confocal, live cell confocal, and spectral confocal imaging, as well as epifluorescence microscopy, image processing, and image analysis. To ensure that that these technologies are properly utilized, CIMC personnel perform comprehensive training sessions and provide consultation on experimental setup, execution, and analysis. Moreover, CIMC personnel provide daily user assistance and perform routine maintenance on all equipment to ensure optimal image acquisition and analysis. The CIMC has also developed an educational web site that provides online scheduling, recent upgrades, and describes the technologies and applications available. The CIMC is a WCI Core, and the WCI is responsible for oversight, operations, budget, compliance, user fee collection, and employee relations. The Core director makes all day-to-day decisions with input from CIMC personnel, users, and internal advisory boards. CIMC services have impacted numerous programmatic initiatives that include biomarker discovery and development, cancer nanotechnology, tumor diagnostics, drug delivery, molecular pharmacology, and cell biology. Furthermore, the CIMC participates in two institution-wide grants and collaborates with several WCI cores and investigators. As a result, the CIMC has users from all WCI programs, and WCI members comprise 78% of total CIMC usage. The CIMC has focused on two areas of technology development[unreadable] cancer nanotechnology and more recently, in vivo (small animal) cellular imaging. These new technologies strengthen the scientific repertoire of the CIMC and ultimately enhance the basic, translational, and clinical initiatives of the WCI.

View original record on NIH RePORTER →